OHSU Knight Cancer Institute
Ryan Li, MD
This clinical trial evaluates the use of virtual reality (VR) goggles during chemotherapy infusion to reduce anxiety-related symptoms in patients with head and neck, thoracic, hematologic, and breast cancers. Virtual reality headsets provide the ability for users to explore a simulated, three-dimensional environment with which users can interact. In virtual reality users can play interactive games, enjoy relaxing experiences, and watch immersive videos. The use of VR goggles may help with anxiety management during chemotherapy infusion.
Hematopoietic and Lymphoid System Neoplasm
Malignant Breast Neoplasm
Malignant Head and Neck Neoplasm
Malignant Solid Neoplasm
Malignant Thoracic Neoplasm
Questionnaire Administration
Telephone-Based Intervention
Virtual Technology Intervention
NA
PRIMARY OBJECTIVE: I. To evaluate the effectiveness of VR therapy in reducing severity of anxiety symptoms during chemotherapy infusion, compared to participants utilizing a smartphone as a control. SECONDARY OBJECTIVES: I. To evaluate whether there is a short-term effect of VR use in anxiety levels. II. To assess participant satisfaction with their chemotherapy infusion experience in the control and treatment groups. EXPLORATORY OBJECTIVE: I. To assess participants' reported adverse effects associated with VR headset use. OUTLINE: Patients are randomized to 1 of 2 groups. GROUP 1: Patients use VR during chemotherapy infusion on study. GROUP 2: Patients use smartphone during chemotherapy infusion on study.
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 50 participants |
Masking : | NONE |
Primary Purpose : | SUPPORTIVE_CARE |
Official Title : | Anxiety in the Context of Chemotherapy Infusion: Is There an Association Between the Use of Virtual Reality Goggles and Changes in Anxiety-Related Symptoms? |
Actual Study Start Date : | 2023-04-20 |
Estimated Primary Completion Date : | 2023-09-28 |
Estimated Study Completion Date : | 2023-09-28 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years to 89 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
OHSU Knight Cancer Institute
Portland, Oregon, United States, 97239